Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04625270
Title A Study of VS-6766 v. VS-6766 + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer With and Without a KRAS Mutation
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Verastem, Inc.

ovarian serous carcinoma

peritoneal carcinoma


Defactinib + RO5126766


Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | CAN | BEL

No variant requirements are available.